Localization of an aminoglycoside (streptomycin) in the inner ear after its systemic administration

Summary We used the simple method of direct cytofluorescence to detect the presence of the aminoglycoside, streptomycin, in the inner ear after its systemic administration. In the cochlea, fluorescence was observed in the organ of Corti, the spiral ganglion, the nerve fibres, the vascular stria and Reissner's membrane; in the vestibulum, fluorescence was seen in the crista ampullaris and the planum semilunatum. The localization of the drug was related to the distribution of its specific receptor, triphosphoinositide (TPI); therefore, it is reasonable to assume that aminoglycosides exert their toxic effects by binding to TPI.Supported by grants of Ministero della Pubblica Istruzione, Italy     

Anthocyanin formation in turnip seedlings (Brassica rapa L.): Evidence for two light steps in the biosynthetic pathway

Summary In turnip seedlings, anthocyanin synthesis can be induced with light as soon as water uptake enables the seed coat to be removed. In very young seedlings the main site of production is in the cotyledons but this moves to the hypocotyl when the period of dark growth, before transfer to the light, is increased. The total amount of anthocyanin formed decreases as the seedlings become older. It is suggested that a substance stored in the cotyledons is needed for anthocyanin synthesis and that this substance disappears during growth in the dark. It cannot be replaced by known anthocyanin precursors such as phenylalanine, acetate, shikimic acid and sugars.Anthocyanin synthesis in the hypocotyl is almost completely prevented when the cotyledons are excised, or covered: no anthocyanin is formed in the hypocotyl when the cotyledons alone are irradiated. Cotyledons that have been excised from the hypocotyl synthesize about as much anthocyanin as is formed in the whole intact seedling, but covering the hypocotyl does not increase the amount formed in the cotyledons. These results suggest that pigment synthesis begins in the cotyledons, where a light reaction is needed for the formation of a precursor; the precursor is translocated to the hypocotyl where a second photochemical reaction is required for anthocyanin synthesis. If translocation to the hypocotyl is prevented, anthocyanin is formed in the cotyledons. The nature of the transported precursor is not yet known.

---

Zusammenfassung In Keimlingen vonBrassica rapa kann Anthocyansynthese durch Licht induziert werden, sobald es möglich ist, die Samenschale zu entfernen. In den jüngsten Keimlingen sind die Kotyledonen der Ort stärkster Anthocyanbildung, in älteren Keimlingen das Hypokotyl. Die Gesamtmenge an gebildetem Anthocyan nimmt mit zunehmendem Alter der Keimlinge ab. Es wird vermutet, daß eine für Anthocyansynthese notwendige Substanz in den Kotyledonen gespeichert ist und während des Wachstums im Dunkeln abnimmt. Diese Substanz konnte durch bekannte Anthocyanvorstufen wie Phenylalanin, Acetat, Shikimisäure und Zucker nicht ersetzt werden.Anthocyansynthese ist im Hypokotyl fast vollständig unterdrückt, wenn die Kotyledonen entfernt oder verdunkelt werden: Kein Anthocyan wird im Hypokotyl gebildet, wenn die Kotyledonen allein belichtet werden. Isolierte Kotyledonen synthetisieren ungefähr die gleiche Menge Anthocyan wie intakte Keimlinge, aber eine Verdunkelung des Hypokotyls bewirkt keine Steigerung der Anthocyanbildung in den Kotyledonen. Diese Ergebnisse lassen vermuten, daß die Synthese von Anthocyan in den Kotyledonen beginnt, wo eine lichtabhängige Reaktion zur Bildung einer Zwischenstufe notwendig ist; diese Zwischenstufe wird in das Hypokotyl transportiert, wo eine zweite photochemische Reaktion für Anthocyansynthese erforderlich ist. Wird der Transport in das Hypokotyl verhindert, findet Anthocyansynthese in den Kotyledonen statt. Über die Natur dieser Zwischenstufe ist jedoch noch nichts bekannt.

---

---

With 9 Figures in the Text     

Type 2 Diabetes—Effect of Compensatory Oversecretion as a Reason for β-Cell Collapse

Insulin secretion declines progressively before and during the course of type 2 diabetes. Evidence indicates that this process is, in part, secondary to increased requirement for insulin secretion that is brought about by insulin resistance and by hyperglycemia. The effects of over-secretion extend far beyond a mere reduction of available insulin stores and may cause not only functional but also structural damage. The time is ripe for clinical studies, which explore the therapeutic potential of reducing over-secretion.